Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

ECL Extra - LumiBlue™ (ab270229)

Price and availability

217 776 ₸

Availability

Order now and get it on Tuesday March 09, 2021

ECL Extra - LumiBlue™ (ab270229)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

You may also be interested in

Product image
Anti-SKA3 antibody - C-terminal (ab186003)
Product image
Anti-Kappa Opioid Receptor antibody [EPR18881] (ab183825)
Product image
Anti-XIAP antibody (ab137392)
Product image
Human MYD88 knockout A549 cell lysate (ab256997)

Overview

  • Product name

    ECL Extra - LumiBlue™
  • Product overview

    ECL Extra - LumiBlue™ (ab270229) is a solution with a high level of signal intensity and is effective for qualitative and quantitative detection across a wide range of protein concentrations. The solution is sensitive enough to detect 500 fg of protein per band and has a signal duration of up to 12 hours. The working solution is stable for up to three days after activation, allowing convenient experiments spanning multiple days and minimising waste.


    ECL Extra - LumiBlue™ is at least 20 times more intense than standard ECL based on phenolic enhancers, allowing lower antibody concentrations and more blots per batch of antibody while still retaining the same sensitivity. This kit provides a comparable level of sensitivity to equivalent ECL kits from leading competitors with the same antibody dilutions, and does not require protocol reoptimization or changes from these kits. 


    Key Benefits of ECL Extra - LumiBlue™ Include:


    Linear response – Novel acylation catalyst provide stable signal over a wide range of protein concentrations


    High sensitivity – Detect protein levels as low as 500 fg per band with next generation enhancers


    Long lasting signal – Perform multiple exposures with less signal loss


    Low background – Optimized formulation for lower backgrounds


    Bright bands – Equal or better brightness compared to other ECL solutions


    Notes


    Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
    It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.


    This product is manufactured by Expedeon, an Abcam company, and was previously called LumiBlue™ ECL Extra. Expedeon product codes ECLA0250 (250 mL) and ECLA0500 (500 mL) are the same as the current sizes of the product: 250 mL and 500 mL, respectively.

  • Notes

    Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
    It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

  • Tested applications

    Suitable for: WBmore details

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 250 ml
    Luminol/enhancer solution 1 unit
    Peroxide solution 1 unit

Images

  • ECL Extra - LumiBlue™ (ab270229)
    ECL Extra - LumiBlue™ (ab270229)

    Unique Technology: LumiBlue™ ECL kits are based on the enzymatic oxidation of luminol with peroxide to produce light usually through horseradish peroxidase (HRP). This method is employed by most traditional ECL kits. However, LumiBlue™ improves upon standard ECL kits by using a patented next generation electron mediator coupled with a novel acylation catalyst to improve performance (called enhancers). The combination of these unique modifications to the ECL process increases reaction efficiency resulting in increased light intensity and less signal decay. The different LumiBlue™ kits are extensively optimized for specific antibody dilutions and protein levels giving higher intensity, longer signal stability and wider linearity over traditional ECL kits. This allows for more flexible and cost-effective experimental design.

    Linear Response: LumiBlue™ ECL solutions are enhanced by a novel acylation catalyst, resulting in a more linear response to HRP levels than conventional ECL solutions. This increases the range of antibody concentrations at which reliable measurement can occur.

  • ECL Extra - LumiBlue™ (ab270229)
    ECL Extra - LumiBlue™ (ab270229)

    Typical results using ECL Extra - LumiBlue™ (ab270229) at a range of HRP dilutions.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Human Histone H3.3 (Mutated G34W, G34V, G34R) Antibody Panel (ab274410)

  •  
  • Product image

    Donkey Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150061)

  •  
  • Product image

    Anti-CD8 alpha antibody [CAL67] - BSA and Azide free (ab251597)

  •  
  • Anti-Hepatitis C Virus Core Antigen antibody [11-B3] (ab18929)

  •  
  • Anti-HSV2 gG Envelope antibody [H1206] (ab53470)

  •  
  • Product image

    Anti-Myc tag antibody [9E10] - BSA and Azide free (ab264603)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.